Bio-Rad Submits Premarket Approval for Fourth-Gen HIV Assay
Bio-Rad Laboratories Inc that it has submitted a Premarket Approval application to the FDA for its fourth-generation HIV assay, the GS HIV Combo Ag/Ab EIA (enzyme immunoassay).
Read MoreBio-Rad Laboratories Inc that it has submitted a Premarket Approval application to the FDA for its fourth-generation HIV assay, the GS HIV Combo Ag/Ab EIA (enzyme immunoassay).
Read MoreSysmex announced the addition of the CellaVision DM1200 cell image analysis analyzer to the Sysmex hematology product offering.
Read MoreSeegene announced the availability of Magicplex Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens
Read MoreHYCOR Biomedical announced new senior executive appointments as the company continues its transformation into a leading global diagnostics company.
Read MoreDr Amar Sethi, VP of Science and Technology at Pacific Biomarkers Inc is the lead author of a research study that identifies the potential use of two diagnostic markers for ischemic heart disease.
Read More